The 36-month beta value for BAX is at 0.59. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 9 as “hold,” and 1 as “sell.”
The public float for BAX is 506.26M, and currently, shorts hold a 2.15% of that float. The average trading volume for BAX on September 24, 2024 was 4.52M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BAX) stock’s latest price update
The stock of Baxter International Inc. (NYSE: BAX) has increased by 1.33 when compared to last closing price of 38.49.Despite this, the company has seen a loss of -3.13% in its stock price over the last five trading days. seekingalpha.com reported 2024-09-19 that Healthcare is undervalued despite being the top sector for earnings growth, making it an attractive investment with solid fundamentals and the potential for explosive returns in 2025. Investing in healthcare ETFs or individual undervalued healthcare stocks can capitalize on the sector’s recovery and expected double-digit growth through 2026. Screening for blue-chip healthcare stocks with solid fundamentals and fair valuations can yield superior returns, including these five coiled spring blue chips.
BAX’s Market Performance
BAX’s stock has fallen by -3.13% in the past week, with a monthly rise of 6.88% and a quarterly rise of 14.07%. The volatility ratio for the week is 2.21% while the volatility levels for the last 30 days are 2.24% for Baxter International Inc. The simple moving average for the last 20 days is 0.78% for BAX’s stock, with a simple moving average of 2.61% for the last 200 days.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Morgan Stanley repeating the rating for BAX by listing it as a “Underweight.” The predicted price for BAX in the upcoming period, according to Morgan Stanley is $30 based on the research report published on July 15, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see BAX reach a price target of $36. The rating they have provided for BAX stocks is “Neutral” according to the report published on May 30th, 2024.
TD Cowen gave a rating of “Hold” to BAX, setting the target price at $40 in the report published on May 10th of the current year.
BAX Trading at 5.51% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.37% of loss for the given period.
Volatility was left at 2.24%, however, over the last 30 days, the volatility rate increased by 2.21%, as shares surge +3.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.42% upper at present.
During the last 5 trading sessions, BAX fell by -3.13%, which changed the moving average for the period of 200-days by +8.94% in comparison to the 20-day moving average, which settled at $38.77. In addition, Baxter International Inc. saw 0.88% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BAX starting from Stevens Brian, who proposed sale 976 shares at the price of $40.01 back on Sep 16 ’24. After this action, Stevens Brian now owns shares of Baxter International Inc., valued at $39,046 using the latest closing price.
Stevens Brian, the Officer of Baxter International Inc., proposed sale 16,063 shares at $39.81 during a trade that took place back on Sep 13 ’24, which means that Stevens Brian is holding shares at $639,465 based on the most recent closing price.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.36 for the gross margin
The net margin for Baxter International Inc. stands at 0.17. The total capital return value is set at 0.05. Equity return is now at value -2.38, with -0.58 for asset returns.
Based on Baxter International Inc. (BAX), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 1.69. The interest coverage ratio of the stock is 2.12.
Currently, EBITDA for the company is 1.75 billion with net debt to EBITDA at 5.66. When we switch over and look at the enterprise to sales, we see a ratio of 2.08. The receivables turnover for the company is 5.57for trailing twelve months and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.40.
Conclusion
In conclusion, Baxter International Inc. (BAX) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
